Softtech Engineers Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 6:58 pm

Quick Insight

Softtech Engineers Ltd, operating in the IT Consulting & Software industry, currently has a share price of 383 with a market capitalization of 528 Cr. The high P/E ratio of 324 suggests an overvalued stock, while the ROE of 0.89% and ROCE of 4.38% indicate relatively low returns on equity and capital employed. With a healthy operating profit margin of 27.32% and a net profit of 1.33 Cr, the company demonstrates operational efficiency. However, the absence of major institutional investors and limited information on shareholders raise concerns about investor confidence. The high borrowings of ₹41.92Cr and negative cash conversion cycle of -256.37 days are red flags for liquidity and working capital management. The price-to-book value ratio of 3.02x and interest coverage ratio of 5.00x further highlight the stock's premium valuation and debt servicing capability. In conclusion, investors should carefully assess Softtech Engineers Ltd's financial health and growth prospects before considering an investment due to the mixed signals from its financial metrics.

Competitors of Softtech Engineers Ltd

All Competitor Stocks of Softtech Engineers Ltd

Quarterly Result

Last Updated: August 20, 2025, 3:20 am

Below is a detailed analysis of the quarterly data for Softtech Engineers Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 27.01 Cr.. The value appears to be declining and may need further review. It has decreased from 31.00 Cr. (Mar 2025) to 27.01 Cr., marking a decrease of 3.99 Cr..
• For Expenses, as of Jun 2025, the value is 19.63 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 26.28 Cr. (Mar 2025) to 19.63 Cr., marking a decrease of 6.65 Cr..
• For Operating Profit, as of Jun 2025, the value is 7.38 Cr.. The value appears strong and on an upward trend. It has increased from 4.72 Cr. (Mar 2025) to 7.38 Cr., marking an increase of 2.66 Cr..
• For OPM %, as of Jun 2025, the value is 27.32%. The value appears strong and on an upward trend. It has increased from 15.23% (Mar 2025) to 27.32%, marking an increase of 12.09%.
• For Other Income, as of Jun 2025, the value is 1.05 Cr.. The value appears to be declining and may need further review. It has decreased from 1.18 Cr. (Mar 2025) to 1.05 Cr., marking a decrease of 0.13 Cr..
• For Interest, as of Jun 2025, the value is 1.07 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.05 Cr. (Mar 2025) to 1.07 Cr., marking an increase of 0.02 Cr..
• For Depreciation, as of Jun 2025, the value is 5.65 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.30 Cr. (Mar 2025) to 5.65 Cr., marking an increase of 1.35 Cr..
• For Profit before tax, as of Jun 2025, the value is 1.71 Cr.. The value appears strong and on an upward trend. It has increased from 0.55 Cr. (Mar 2025) to 1.71 Cr., marking an increase of 1.16 Cr..
• For Tax %, as of Jun 2025, the value is 35.67%. The value appears to be improving (decreasing) as expected. It has decreased from 87.27% (Mar 2025) to 35.67%, marking a decrease of 51.60%.
• For Net Profit, as of Jun 2025, the value is 1.11 Cr.. The value appears strong and on an upward trend. It has increased from 0.07 Cr. (Mar 2025) to 1.11 Cr., marking an increase of 1.04 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.69. The value appears strong and on an upward trend. It has increased from 0.03 (Mar 2025) to 0.69, marking an increase of 0.66.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:01 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:19 am

Below is a detailed analysis of the balance sheet data for Softtech Engineers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 13.81 Cr.. The value appears strong and on an upward trend. It has increased from 12.82 Cr. (Mar 2024) to 13.81 Cr., marking an increase of 0.99 Cr..
• For Reserves, as of Mar 2025, the value is 154.96 Cr.. The value appears strong and on an upward trend. It has increased from 113.27 Cr. (Mar 2024) to 154.96 Cr., marking an increase of 41.69 Cr..
• For Borrowings, as of Mar 2025, the value is 41.92 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 38.50 Cr. (Mar 2024) to 41.92 Cr., marking an increase of 3.42 Cr..
• For Other Liabilities, as of Mar 2025, the value is 37.20 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 30.22 Cr. (Mar 2024) to 37.20 Cr., marking an increase of 6.98 Cr..
• For Total Liabilities, as of Mar 2025, the value is 247.89 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 194.81 Cr. (Mar 2024) to 247.89 Cr., marking an increase of 53.08 Cr..
• For Fixed Assets, as of Mar 2025, the value is 84.15 Cr.. The value appears strong and on an upward trend. It has increased from 50.09 Cr. (Mar 2024) to 84.15 Cr., marking an increase of 34.06 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.66 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 16.66 Cr..
• For Investments, as of Mar 2025, the value is 9.71 Cr.. The value appears to be declining and may need further review. It has decreased from 15.40 Cr. (Mar 2024) to 9.71 Cr., marking a decrease of 5.69 Cr..
• For Other Assets, as of Mar 2025, the value is 154.03 Cr.. The value appears strong and on an upward trend. It has increased from 112.66 Cr. (Mar 2024) to 154.03 Cr., marking an increase of 41.37 Cr..
• For Total Assets, as of Mar 2025, the value is 247.89 Cr.. The value appears strong and on an upward trend. It has increased from 194.81 Cr. (Mar 2024) to 247.89 Cr., marking an increase of 53.08 Cr..

Notably, the Reserves (154.96 Cr.) exceed the Borrowings (41.92 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Softtech Engineers Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 1.00. This value is below the healthy minimum of 5. It has decreased from 3.17 (Mar 24) to 1.00, marking a decrease of 2.17.
• For Diluted EPS (Rs.), as of Mar 25, the value is 1.00. This value is below the healthy minimum of 5. It has decreased from 3.17 (Mar 24) to 1.00, marking a decrease of 2.17.
• For Cash EPS (Rs.), as of Mar 25, the value is 12.80. This value is within the healthy range. It has decreased from 13.08 (Mar 24) to 12.80, marking a decrease of 0.28.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 122.23. It has increased from 97.58 (Mar 24) to 122.23, marking an increase of 24.65.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 122.23. It has increased from 97.58 (Mar 24) to 122.23, marking an increase of 24.65.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 68.99. It has increased from 61.45 (Mar 24) to 68.99, marking an increase of 7.54.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 17.75. This value is within the healthy range. It has decreased from 18.44 (Mar 24) to 17.75, marking a decrease of 0.69.
• For PBIT / Share (Rs.), as of Mar 25, the value is 5.92. This value is within the healthy range. It has decreased from 7.96 (Mar 24) to 5.92, marking a decrease of 2.04.
• For PBT / Share (Rs.), as of Mar 25, the value is 2.37. This value is within the healthy range. It has decreased from 4.40 (Mar 24) to 2.37, marking a decrease of 2.03.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 2. It has decreased from 2.59 (Mar 24) to 0.96, marking a decrease of 1.63.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 2. It has decreased from 2.79 (Mar 24) to 0.95, marking a decrease of 1.84.
• For PBDIT Margin (%), as of Mar 25, the value is 25.73. This value is within the healthy range. It has decreased from 30.01 (Mar 24) to 25.73, marking a decrease of 4.28.
• For PBIT Margin (%), as of Mar 25, the value is 8.58. This value is below the healthy minimum of 10. It has decreased from 12.94 (Mar 24) to 8.58, marking a decrease of 4.36.
• For PBT Margin (%), as of Mar 25, the value is 3.43. This value is below the healthy minimum of 10. It has decreased from 7.16 (Mar 24) to 3.43, marking a decrease of 3.73.
• For Net Profit Margin (%), as of Mar 25, the value is 1.39. This value is below the healthy minimum of 5. It has decreased from 4.22 (Mar 24) to 1.39, marking a decrease of 2.83.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.37. This value is below the healthy minimum of 8. It has decreased from 4.54 (Mar 24) to 1.37, marking a decrease of 3.17.
• For Return on Networth / Equity (%), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 15. It has decreased from 2.86 (Mar 24) to 0.77, marking a decrease of 2.09.
• For Return on Capital Employeed (%), as of Mar 25, the value is 4.48. This value is below the healthy minimum of 10. It has decreased from 7.43 (Mar 24) to 4.48, marking a decrease of 2.95.
• For Return On Assets (%), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 5. It has decreased from 1.83 (Mar 24) to 0.53, marking a decrease of 1.30.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.03.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. It has decreased from 0.25 (Mar 24) to 0.20, marking a decrease of 0.05.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.43. It has decreased from 0.44 (Mar 24) to 0.43, marking a decrease of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 2.14. This value is within the healthy range. It has increased from 1.86 (Mar 24) to 2.14, marking an increase of 0.28.
• For Quick Ratio (X), as of Mar 25, the value is 2.12. This value exceeds the healthy maximum of 2. It has increased from 1.86 (Mar 24) to 2.12, marking an increase of 0.26.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.00. This value is within the healthy range. It has decreased from 5.19 (Mar 24) to 5.00, marking a decrease of 0.19.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.27. This value is below the healthy minimum of 3. It has decreased from 1.73 (Mar 24) to 1.27, marking a decrease of 0.46.
• For Enterprise Value (Cr.), as of Mar 25, the value is 506.25. It has increased from 413.19 (Mar 24) to 506.25, marking an increase of 93.06.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.31. This value exceeds the healthy maximum of 3. It has increased from 5.25 (Mar 24) to 5.31, marking an increase of 0.06.
• For EV / EBITDA (X), as of Mar 25, the value is 20.65. This value exceeds the healthy maximum of 15. It has increased from 17.48 (Mar 24) to 20.65, marking an increase of 3.17.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.35. This value exceeds the healthy maximum of 3. It has increased from 4.86 (Mar 24) to 5.35, marking an increase of 0.49.
• For Price / BV (X), as of Mar 25, the value is 3.02. This value exceeds the healthy maximum of 3. It has decreased from 3.06 (Mar 24) to 3.02, marking a decrease of 0.04.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.35. This value exceeds the healthy maximum of 3. It has increased from 4.86 (Mar 24) to 5.35, marking an increase of 0.49.
• For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness